First Time Loading...

Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 70.39 USD 0.1% Market Closed
Updated: May 12, 2024

Prestige Consumer Healthcare Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Prestige Consumer Healthcare Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Prestige Consumer Healthcare Inc
NYSE:PBH
Cash & Cash Equivalents
$63.6m
CAGR 3-Years
1%
CAGR 5-Years
21%
CAGR 10-Years
-4%
Johnson & Johnson
NYSE:JNJ
Cash & Cash Equivalents
$7.2B
CAGR 3-Years
19%
CAGR 5-Years
1%
CAGR 10-Years
-10%
Bristol-Myers Squibb Co
NYSE:BMY
Cash & Cash Equivalents
$9.3B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
6%
Pfizer Inc
NYSE:PFE
Cash & Cash Equivalents
$2.9B
CAGR 3-Years
17%
CAGR 5-Years
8%
CAGR 10-Years
0%
Merck & Co Inc
NYSE:MRK
Cash & Cash Equivalents
$5.6B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Cash & Cash Equivalents
$2.5B
CAGR 3-Years
-6%
CAGR 5-Years
4%
CAGR 10-Years
-4%

See Also

What is Prestige Consumer Healthcare Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
63.6m USD

Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Cash & Cash Equivalents amounts to 63.6m USD.

What is Prestige Consumer Healthcare Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-4%

Over the last year, the Cash & Cash Equivalents growth was -26%. The average annual Cash & Cash Equivalents growth rates for Prestige Consumer Healthcare Inc have been 1% over the past three years , 21% over the past five years , and -4% over the past ten years .